SOP Guide for Pharma

Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing – V 2.0

Sterile Injectable Manufacturing: SOP for Subcutaneous Injection Batch Manufacturing – V 2.0

Standard Operating Procedure for Subcutaneous Injection Batch Manufacturing


Department Sterile Injectable Manufacturing
SOP No. SOP/SIM/023/2025
Supersedes SOP/SIM/023/2022
Page No. Page 1 of 14
Issue Date 18/06/2025
Effective Date 20/06/2025
Review Date 18/06/2026

1. Purpose

This SOP describes the detailed process for the batch manufacturing of subcutaneous (SC) injection products in a sterile manufacturing environment, in accordance with GMP and regulatory standards to ensure product safety, efficacy, and batch-to-batch consistency.

2. Scope

This

SOP is applicable to all activities involved in the preparation, filtration, aseptic filling, sealing, and packaging of SC injection products manufactured within the sterile injectable department.

3. Responsibilities

  • Manufacturing Officer: Executes formulation, filling, and documentation as per BMR.
  • Quality Assurance Officer: Monitors compliance and reviews records.
  • Microbiologist: Conducts environmental and sterility monitoring.
  • Maintenance Engineer: Ensures equipment functionality and preventive maintenance.

4. Accountability

The Head of Manufacturing is accountable for implementation, compliance, and final batch release readiness.

5. Procedure

5.1 Pre-Manufacturing Checks

  1. Ensure the manufacturing area is cleaned and sanitized. Record in area cleaning log.
  2. Verify calibration status and cleanliness of equipment to be used.
  3. Ensure availability of approved BMR and verify raw material quantities.

5.2 Formulation Preparation

  1. Transfer pre-weighed materials from dispensing to manufacturing via pass box.
  2. Dissolve APIs and excipients in Water for Injection (WFI) in SS316L compounding vessel.
  3. Maintain temperature (if required) and stir with validated agitator until homogenous.
  4. Record batch number, temperature, pH, and mixing time in Annexure-1.

5.3 Filtration and Sterile Transfer

  1. Filter solution through 0.45 µm and then 0.22 µm sterile-grade membrane filters.
  2. Use sterile tubing and transfer the solution aseptically to the filling vessel under LAF.
  3. Perform pre- and post-filtration integrity tests. Record in Annexure-2.

5.4 Aseptic Filling and Sealing

  1. Load cleaned and sterilized vials or prefilled syringes into filling line.
  2. Fill the formulation as per volume specifications under Grade A environment.
  3. Seal using pre-validated capping or plunger-sealing equipment.
  4. Inspect filled containers visually for particles, leaks, and proper volume (Annexure-3).

5.5 In-Process Controls

  1. Verify volume fill accuracy, appearance, and clarity of solution every 30 minutes.
  2. Check environmental conditions – temperature, humidity, differential pressure.
  3. Record all results in Annexure-4: IPC Log.

5.6 Batch Completion

  1. Transfer filled units to quarantine area labeled as “Under QC.”
  2. Clean the equipment and area according to respective cleaning SOPs.
  3. Ensure BMR entries are completed and signed by QA and production.

6. Abbreviations

  • SC: Subcutaneous
  • BMR: Batch Manufacturing Record
  • QA: Quality Assurance
  • WFI: Water for Injection
  • LAF: Laminar Air Flow

7. Documents

  1. Batch Manufacturing Log – Annexure-1
  2. Filter Integrity Report – Annexure-2
  3. Visual Inspection Report – Annexure-3
  4. In-Process Control Log – Annexure-4

8. References

  • ICH Q8 – Pharmaceutical Development
  • WHO GMP for Sterile Pharmaceutical Products
  • Schedule M – Indian Drugs & Cosmetics Act

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name Deepa Nair Ravi Deshmukh Dr. Vandana Shah
Designation Production Officer QA Executive QA Head
Department Manufacturing Quality Assurance Quality Assurance

11. Annexures

Annexure-1: Batch Manufacturing Log

Date Batch No. pH Temp (°C) Mix Time Operator
17/06/2025 SC/0625/07 6.2 25 45 min Suraj Patil

Annexure-2: Filter Integrity Report

Filter ID Type Pre-Test Post-Test Status
FILT-SC-02 0.22 µm Pass Pass Pass

Annexure-3: Visual Inspection Report

Unit No. Clarity Foreign Particles Seal Result
SC00741 Clear Absent Intact Pass

Annexure-4: In-Process Control Log

Time Fill Volume Clarity Temp (°C) Remarks
10:30 0.9 mL Clear 24.5 OK

Revision History

Revision Date Revision No. Details Reason Approved By
12/01/2022 1.0 Initial Issue New SOP QA Head
18/06/2025 2.0 Updated for latest validation procedures and annexures Annual Review QA Head
Exit mobile version